Abstract
Encapsulated carcinomas of follicular cell origin are subject to considerable controversies. This group includes an encapsulated/well-circumscribed (E/WC) follicular variant of papillary carcinoma (FVPTC) and encapsulated follicular and Hurthle cell carcinoma (EFC, EHC respectively). FVPTC usually presents as an E/WC tumor and less commonly as an infiltrative neoplasm. E/WC FVPTC rarely metastasizes to lymph nodes, whereas infiltrative tumors often present with cervical nodal metastases. Many studies revealed FVPTC in general to be genetically close to the follicular adenomas (FA)/EFC group of tumors. This is particularly true for the E/WC FVPTC which has a high rate of RAS and lack BRAFV600E mutations. Infiltrative FVPTC has an opposite molecular profile closer to classical papillary carcinoma than to FA/EFC (BRAFV600E > RAS mutations). Noninvasive E/WC FVPTCs are extremely indolent even if treated with lobectomy alone. While EFC and EHC with capsular invasion only have an excellent outcome, those with extensive (≥4 foci) lymphovascular invasion (LVI) have a significant rate of distant recurrence. The prognosis of those with focal LVI seems good, but more studies are needed to confirm their behavior. In EHC, those with extensive/significant LVI have a different RNA expression profile than those with less LVI. EHC appear to recur earlier, are less RAI avid, and have a different mutation profile than EFC. Noninvasive E/WC FVPTC should be treated conservatively. There is therefore a need to reclassify the E/WC FVPTC in order to prevent overtreatment. In view of their molecular and behavioral differences, EHC should not be considered a subset of EFC.
Similar content being viewed by others
References
Passler C, Prager G, Scheuba C, et al. Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch Surg 138:1362-1366, 2003.
Carcangiu ML, Zampi G, Pupi A, et al. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55:805-828, 1985.
Tielens ET, Sherman SI, Hruban RH, et al. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer 73:424-431, 1994.
Sebastian SO, Gonzalez JM, Paricio PP, et al. Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch Surg 135:272-277, 2000.
Jung CK, Little MP, Lubin JH, Brenner AV, Wells SA Jr., Sigurdson AJ, Nikiforov YE. The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency of BRAF Mutations and a Sharp Increase in RAS Mutations. J Clin Endocrinol Metab. 99: E276–E285, 2014.
Rosai J, Carcangiu ML, Delellis RA. Tumors of the Thyroid Gland, Atlas of Tumor Pathology. Washington, Armed Forces Institute of Pathology, 161-182, 1992.
Chan JK. Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 117:16-18, 2002.
Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 28:1336-1340, 2004.
Elsheikh TM, Asa SL, Chan JK et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol 130:736-744, 2008.
Solomon BL, Wartofsky L, Burman KD. Current trends in the management of well differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 81:333-9, 1996.
Cooper DS, Doherty GM, Haugen BR: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid: Official journal of the American Thyroid Association.; 19:1167-1214, 2009.
Baloch ZW, LiVolsi VA. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol 13:861-865, 2000.
Zhu Z, Gandhi M, Nikiforova MN, et al. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol 120:71-77, 2003.
Jain M, Khan A, Patwardhan N, et al. Follicular variant of papillary thyroid carcinoma: a comparative study of histopathologic features and cytology results in 141 patients. Endocr Pract 7:79-84, 2001.
Wreesmann VB, Ghossein RA, Hezel M, et al. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer 40:355-364, 2004.
Castro P, Rebocho AP, Soares RJ, et al. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 91:213-220, 2006.
Cancer Genome Atlas Research Network. Cell. 23; 159(3):676-690, 2014.
Liu J, Singh B, Tallini G et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107:1255-1264, 2006.
Rivera M, Ricarte-Filho J, Knauf J, Tuttle RM, Fagin J, Ghossein R, et al. Molecular Genotyping of Papillary Thyroid Carcinoma Follicular Variant According to Its Histologic Subtypes (Encapsulated vs Non-Encapsulated Infiltrative) Reveals Distinct BRAF and RAS Mutation Patterns. Mod Pathol 23:1191-1200, 2010.
Piana S, Frasoldati A, Di Felice E, Gardini G, Tallini G, Rosai J et al. Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma. Am J Surg Pathol 34:868-872, 2010.
Ganly I, Wang L, Tuttle RM, Katabi N, Ceballos GA, Harach HR, Ghossein R. Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant. Hum Pathol 46:657-664, 2015.
Vivero M, Kraft S, Barletta JA. Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid 23(3):273-279, 2013.
Rosario PW, Penna GC, Calsolari MR. Noninvasive encapsulated follicular variant of papillary thyroid carcinoma: is lobectomy sufficient for tumours ≥1 cm? Clin Endocrinol (letter) 81:630-632, 2013.
Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the english literature. Cancer. 91:505-524, 2001.
Evans HL, Vassilopoulou-Sellin R. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study. Am J Surg Pathol. 22: 1512-1520, 1998.
National Comprehensive Cancer Network guidelines for thyroid carcinoma. 2012 version. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
Van Heerden JA, Hay ID, Goellner JR et al. Follicular thyroid carcinoma with capsular invasion alone: A non-threatening malignancy. Surgery 112:1130-1136, 1992.
Lang W, Choritz H, Hundeshagen H. Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol. 10: 246-255, 1986.
Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 117:143-150, 2002.
Stojadinovic A, Ghossein RA, Hoos A, et al. Hurthle cell carcinoma: a critical histopathologic appraisal. J Clin Oncol. 19:2616–2625, 2001.
Ghossein RA, Hiltzik DH, Carlson DL et al. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer. 106:1669-1676, 2006.
Collini P, Sampietro G, Pilotti S. Extensive vascular invasion is a marker of risk of relapse in encapsulated non-Hurthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with a 11-year median follow-up. Histopathology. 44: 35-39, 2004.
Ghossein R, Xu B, Wang L, Tuttle RM, Ganly I. Prognostic impact of extent of vascular invasion in low grade encapsulated follicular cell derived thyroid carcinoma: A clinico-pathologic study of 276 cases Mod Pathol 28: 134A (Abstract 526). 2015.
Kahn NF, Perzin KH. Follicular carcinoma of the thyroid: an evaluation of the histologic criteria used for diagnosis. Pathol Annu. 18(Pt 1): 221-253, 1983.
Goldstein NS, Czako P, Neill JS. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: a study of 34 patients. Mod Pathol.13:123-130, 2000.
Mete O, Asa SL. Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol. 24:1545-1552, 2011.
Ganly I, Ricarte Filho J, Eng S, Ghossein R, Morris LG, Liang Y, Socci N, Kannan K, Mo Q, Fagin JA, Chan TA. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. Clin Endocrinol Metab 98: E962–E972, 2013.
DeLellis RA, Lloyd RV, Heitz PU, Eng C. Pathology and Genetics of Tumours of the Endocrine Organs. Lyon, France:: IARC Press; 2004.
Talini G et al. Frequent chromosomal imbalance in thyroid oncocytic (Hurthle cell) neoplasms detected by comparative genomic hybridisation. Lab Invest. 79:547–555, 1999.
Bhaijee F, Nikiforov YE. Molecular analysis of thyroid tumors. Endocr Pathol 22:126-133, 2011.
Ricarte-Filho JC, Ryder M, Chitale DA, Rivera M, Heguy A, Ladanyi M, Janakiraman M, Solit D, Knauf JA, Tuttle RM, Ghossein RA, Fagin JA. Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Res. 69:4885-4893, 2009.
Lopez-Penabad L, Chiu AC, Hoff AO, et al. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer. 97:1186–1194, 2003.
Tala HP, Rondeau G, Ghossein RA, Fagin JA, Grewal RK, Larson SM, Tuttle RM. Histologically aggressive types of follicular cell-derived thyroid cancer often have radioactive avid distant metastases: a study of 314 patients with distant metastases at a single institution. Abstract 2679. International Thyroid Cancer Meeting 2010.
Kim WG et al. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data Korean J Int Med: 29:325-333, 2014.
Conflict of Interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xu, B., Ghossein, R. Encapsulated Thyroid Carcinoma of Follicular Cell Origin. Endocr Pathol 26, 191–199 (2015). https://doi.org/10.1007/s12022-015-9376-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-015-9376-5